NEWARK, N.J.--(BUSINESS WIRE)--Urovalve, a medical device company focused on creating products for urinary flow and control, announced today that it has received funding from the New Jersey Economic Development Agency (NJEDA) to advance development of its Surinate® Bladder Management System—designed to improve the quality of life of men who suffer from acute or chronic urinary retention, an inability to empty the bladder.
